COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    CIVO | Soft Tissue Sarcoma
Previous Study | Return to List | Next Study

Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO™ Device in Soft Tissue Sarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03056599
Recruitment Status : Recruiting
First Posted : February 17, 2017
Last Update Posted : February 7, 2020
Fred Hutchinson Cancer Research Center
University of Washington
Northwell Health
Oregon Health and Science University
Information provided by (Responsible Party):
Presage Biosciences

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : June 30, 2020